MedTrace Logo

Substudy of CADRE: for People With Extreme Phenotype: BIOCADRE

NCT03352986 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-11-24

No results posted yet for this study

Summary

BIOCADRE is a CADRE substudy and aims to characterize more precisely the sickle cell patients with extreme phenotype.

Conditions

Interventions

BIOLOGICAL

biological analysis

biological analysis will be performed in the 6 groups of patients

OTHER

peripheral arterial tonometry

peripheral arterial tonometry will be performed in the 6 groups of patients

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Cardiologie et Développement

    lead OTHER

Principal Investigators

  • Brigitte Ranque, MD · Institut National de la Santé Et de la Recherche Médicale, France

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2019-06-30
Completion
2019-12-31

Countries

  • Mali
  • Senegal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03352986 on ClinicalTrials.gov